-
Social media and clinical research
Christopher Hart
Editorial: Clinical Investigation
-
Social media and clinical research
Christopher Hart
Editorial: Clinical Investigation
-
Social media and clinical research
Christopher Hart
Editorial: Clinical Investigation
-
Social media and clinical research
Christopher Hart
Editorial: Clinical Investigation
-
Social media and clinical research
Christopher Hart
Editorial: Clinical Investigation
-
Social media and clinical research
Christopher Hart
Editorial: Clinical Investigation
-
Social media and clinical research
Christopher Hart
Editorial: Clinical Investigation
-
Social media and clinical research
Christopher Hart
Editorial: Clinical Investigation
-
The importance of considering ADHD in smoking cessation clinical trials
L Cinnamon Bidwell & Adam M Leventhal
Editorial: Clinical Investigation
-
The importance of considering ADHD in smoking cessation clinical trials
L Cinnamon Bidwell & Adam M Leventhal
Editorial: Clinical Investigation
-
The importance of considering ADHD in smoking cessation clinical trials
L Cinnamon Bidwell & Adam M Leventhal
Editorial: Clinical Investigation
-
The importance of considering ADHD in smoking cessation clinical trials
L Cinnamon Bidwell & Adam M Leventhal
Editorial: Clinical Investigation
-
The importance of considering ADHD in smoking cessation clinical trials
L Cinnamon Bidwell & Adam M Leventhal
Editorial: Clinical Investigation
-
The importance of considering ADHD in smoking cessation clinical trials
L Cinnamon Bidwell & Adam M Leventhal
Editorial: Clinical Investigation
-
The importance of considering ADHD in smoking cessation clinical trials
L Cinnamon Bidwell & Adam M Leventhal
Editorial: Clinical Investigation
-
The importance of considering ADHD in smoking cessation clinical trials
L Cinnamon Bidwell & Adam M Leventhal
Editorial: Clinical Investigation
-
Surrogate end points: when should they be used?
Geert Molenberghs, Ariel Alonso Abad, Wim van der Elst, Tomasz Burzykowski, Marc Buyse
Review Article: Clinical Investigation
-
Surrogate end points: when should they be used?
Geert Molenberghs, Ariel Alonso Abad, Wim van der Elst, Tomasz Burzykowski, Marc Buyse
Review Article: Clinical Investigation
-
Surrogate end points: when should they be used?
Geert Molenberghs, Ariel Alonso Abad, Wim van der Elst, Tomasz Burzykowski, Marc Buyse
Review Article: Clinical Investigation
-
Surrogate end points: when should they be used?
Geert Molenberghs, Ariel Alonso Abad, Wim van der Elst, Tomasz Burzykowski, Marc Buyse
Review Article: Clinical Investigation
-
Surrogate end points: when should they be used?
Geert Molenberghs, Ariel Alonso Abad, Wim van der Elst, Tomasz Burzykowski, Marc Buyse
Review Article: Clinical Investigation
-
Surrogate end points: when should they be used?
Geert Molenberghs, Ariel Alonso Abad, Wim van der Elst, Tomasz Burzykowski, Marc Buyse
Review Article: Clinical Investigation
-
Surrogate end points: when should they be used?
Geert Molenberghs, Ariel Alonso Abad, Wim van der Elst, Tomasz Burzykowski, Marc Buyse
Review Article: Clinical Investigation
-
Surrogate end points: when should they be used?
Geert Molenberghs, Ariel Alonso Abad, Wim van der Elst, Tomasz Burzykowski, Marc Buyse
Review Article: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 10
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 10
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 10
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 10
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 10
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 10
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 10
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 10
Acknowledgements: Clinical Investigation
-
Everolimus for the treatment of advanced pancreatic neuroendocrine tumors
Paola Tomassetti, Monica Cevenini, Elena Guidetti, Giulia Cacciari, Maria Luigia Cipollini, Elena Galassi, Maria Camilla Fabbri, Francesca Nori, Davide Campana, Roberto Corinaldesi ,Roberto De Giorgio
Review: Clinical Trail Outcomes: Clinical Investigation
-
Everolimus for the treatment of advanced pancreatic neuroendocrine tumors
Paola Tomassetti, Monica Cevenini, Elena Guidetti, Giulia Cacciari, Maria Luigia Cipollini, Elena Galassi, Maria Camilla Fabbri, Francesca Nori, Davide Campana, Roberto Corinaldesi ,Roberto De Giorgio
Review: Clinical Trail Outcomes: Clinical Investigation
-
Everolimus for the treatment of advanced pancreatic neuroendocrine tumors
Paola Tomassetti, Monica Cevenini, Elena Guidetti, Giulia Cacciari, Maria Luigia Cipollini, Elena Galassi, Maria Camilla Fabbri, Francesca Nori, Davide Campana, Roberto Corinaldesi ,Roberto De Giorgio
Review: Clinical Trail Outcomes: Clinical Investigation
-
Everolimus for the treatment of advanced pancreatic neuroendocrine tumors
Paola Tomassetti, Monica Cevenini, Elena Guidetti, Giulia Cacciari, Maria Luigia Cipollini, Elena Galassi, Maria Camilla Fabbri, Francesca Nori, Davide Campana, Roberto Corinaldesi ,Roberto De Giorgio
Review: Clinical Trail Outcomes: Clinical Investigation
-
Everolimus for the treatment of advanced pancreatic neuroendocrine tumors
Paola Tomassetti, Monica Cevenini, Elena Guidetti, Giulia Cacciari, Maria Luigia Cipollini, Elena Galassi, Maria Camilla Fabbri, Francesca Nori, Davide Campana, Roberto Corinaldesi ,Roberto De Giorgio
Review: Clinical Trail Outcomes: Clinical Investigation
-
Everolimus for the treatment of advanced pancreatic neuroendocrine tumors
Paola Tomassetti, Monica Cevenini, Elena Guidetti, Giulia Cacciari, Maria Luigia Cipollini, Elena Galassi, Maria Camilla Fabbri, Francesca Nori, Davide Campana, Roberto Corinaldesi ,Roberto De Giorgio
Review: Clinical Trail Outcomes: Clinical Investigation
-
Everolimus for the treatment of advanced pancreatic neuroendocrine tumors
Paola Tomassetti, Monica Cevenini, Elena Guidetti, Giulia Cacciari, Maria Luigia Cipollini, Elena Galassi, Maria Camilla Fabbri, Francesca Nori, Davide Campana, Roberto Corinaldesi ,Roberto De Giorgio
Review: Clinical Trail Outcomes: Clinical Investigation
-
Everolimus for the treatment of advanced pancreatic neuroendocrine tumors
Paola Tomassetti, Monica Cevenini, Elena Guidetti, Giulia Cacciari, Maria Luigia Cipollini, Elena Galassi, Maria Camilla Fabbri, Francesca Nori, Davide Campana, Roberto Corinaldesi ,Roberto De Giorgio
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical trials in idiopathic pulmonary fibrosis: update and perspectives
Eva Baroke, Shyam Maharaj, Martin Kolb
Review Article: Clinical Investigation
-
Clinical trials in idiopathic pulmonary fibrosis: update and perspectives
Eva Baroke, Shyam Maharaj, Martin Kolb
Review Article: Clinical Investigation
-
Clinical trials in idiopathic pulmonary fibrosis: update and perspectives
Eva Baroke, Shyam Maharaj, Martin Kolb
Review Article: Clinical Investigation
-
Clinical trials in idiopathic pulmonary fibrosis: update and perspectives
Eva Baroke, Shyam Maharaj, Martin Kolb
Review Article: Clinical Investigation
-
Clinical trials in idiopathic pulmonary fibrosis: update and perspectives
Eva Baroke, Shyam Maharaj, Martin Kolb
Review Article: Clinical Investigation
-
Clinical trials in idiopathic pulmonary fibrosis: update and perspectives
Eva Baroke, Shyam Maharaj, Martin Kolb
Review Article: Clinical Investigation
-
Clinical trials in idiopathic pulmonary fibrosis: update and perspectives
Eva Baroke, Shyam Maharaj, Martin Kolb
Review Article: Clinical Investigation
-
Clinical trials in idiopathic pulmonary fibrosis: update and perspectives
Eva Baroke, Shyam Maharaj, Martin Kolb
Review Article: Clinical Investigation
-
Roflumilast for the treatment of respiratory disease: review of the Phase II and III trials
Sabina Antonela Antoniu
Review Article: Clinical Investigation
-
Roflumilast for the treatment of respiratory disease: review of the Phase II and III trials
Sabina Antonela Antoniu
Review Article: Clinical Investigation
-
Roflumilast for the treatment of respiratory disease: review of the Phase II and III trials
Sabina Antonela Antoniu
Review Article: Clinical Investigation
-
Roflumilast for the treatment of respiratory disease: review of the Phase II and III trials
Sabina Antonela Antoniu
Review Article: Clinical Investigation
-
Roflumilast for the treatment of respiratory disease: review of the Phase II and III trials
Sabina Antonela Antoniu
Review Article: Clinical Investigation
-
Roflumilast for the treatment of respiratory disease: review of the Phase II and III trials
Sabina Antonela Antoniu
Review Article: Clinical Investigation
-
Roflumilast for the treatment of respiratory disease: review of the Phase II and III trials
Sabina Antonela Antoniu
Review Article: Clinical Investigation
-
Roflumilast for the treatment of respiratory disease: review of the Phase II and III trials
Sabina Antonela Antoniu
Review Article: Clinical Investigation